JP2009518447A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009518447A5 JP2009518447A5 JP2008544662A JP2008544662A JP2009518447A5 JP 2009518447 A5 JP2009518447 A5 JP 2009518447A5 JP 2008544662 A JP2008544662 A JP 2008544662A JP 2008544662 A JP2008544662 A JP 2008544662A JP 2009518447 A5 JP2009518447 A5 JP 2009518447A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- antibody
- proteasome inhibitor
- fragment
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74915205P | 2005-12-09 | 2005-12-09 | |
| PCT/US2006/061786 WO2007067976A2 (en) | 2005-12-09 | 2006-12-08 | Method of using il6 antagonists with proteasome inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009518447A JP2009518447A (ja) | 2009-05-07 |
| JP2009518447A5 true JP2009518447A5 (https=) | 2009-11-12 |
Family
ID=38123650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008544662A Pending JP2009518447A (ja) | 2005-12-09 | 2006-12-08 | プロテアソームインヒビターと併せたｉｌ６アンタゴニストの使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090022726A1 (https=) |
| EP (1) | EP1954310A4 (https=) |
| JP (1) | JP2009518447A (https=) |
| KR (1) | KR20080072761A (https=) |
| CN (1) | CN101325969A (https=) |
| AR (1) | AR057227A1 (https=) |
| AU (1) | AU2006321610A1 (https=) |
| BR (1) | BRPI0619498A2 (https=) |
| CA (1) | CA2632732A1 (https=) |
| EA (1) | EA014675B1 (https=) |
| IL (1) | IL191694A0 (https=) |
| NO (1) | NO20082907L (https=) |
| TW (1) | TW200803895A (https=) |
| WO (1) | WO2007067976A2 (https=) |
| ZA (1) | ZA200805956B (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8129346B2 (en) | 2004-04-15 | 2012-03-06 | Onyx Therapeutics, Inc. | Compounds for enzyme inhibition |
| US8198270B2 (en) | 2004-04-15 | 2012-06-12 | Onyx Therapeutics, Inc. | Compounds for proteasome enzyme inhibition |
| EP2030981B1 (en) | 2004-05-10 | 2014-07-09 | Onyx Therapeutics, Inc. | Compounds for proteasome enzyme inhibition |
| AR058135A1 (es) * | 2005-10-21 | 2008-01-23 | Chugai Pharmaceutical Co Ltd | Agentes para el tratamiento de cardiopatias |
| MY171061A (en) | 2005-11-09 | 2019-09-24 | Onyx Therapeutics Inc | Compounds for enzyme inhibition |
| AR057582A1 (es) * | 2005-11-15 | 2007-12-05 | Nat Hospital Organization | Agentes para suprimir la induccion de linfocitos t citotoxicos |
| AU2007208678B2 (en) * | 2006-01-27 | 2013-01-10 | Chugai Seiyaku Kabushiki Kaisha | Therapeutic agents for diseases involving choroidal neovascularization |
| JP5754875B2 (ja) | 2006-04-07 | 2015-07-29 | 国立大学法人大阪大学 | 筋再生促進剤 |
| CA2657213C (en) | 2006-06-19 | 2017-01-03 | Proteolix, Inc. | Peptide epoxyketones for proteasome inhibition |
| TWI438208B (zh) | 2007-01-23 | 2014-05-21 | 中外製藥股份有限公司 | 抑制慢性排斥反應之藥劑 |
| EP2174667B1 (en) * | 2007-07-26 | 2017-01-04 | Osaka University | Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| KR20170125413A (ko) | 2007-10-04 | 2017-11-14 | 오닉스 세라퓨틱스, 인크. | 결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성 |
| CA2728243C (en) * | 2008-06-05 | 2020-03-10 | Chugai Seiyaku Kabushiki Kaisha | Il-6 inhibitor for suppressing neuroinvasion in pancreatic cancer |
| EA201170527A1 (ru) * | 2008-10-01 | 2011-10-31 | Др. Редди'С Лабораторис Лтд. | Фармацевтические композиции, включающие соединения бороновой кислоты |
| EP3090737A1 (en) | 2008-10-21 | 2016-11-09 | Onyx Therapeutics, Inc. | Combination therapy with peptide epoxyketones |
| KR20160091440A (ko) * | 2008-11-13 | 2016-08-02 | 길리아드 칼리스토가 엘엘씨 | 혈액 종양에 대한 요법 |
| US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
| WO2011006273A1 (en) | 2009-07-15 | 2011-01-20 | Eva Kovacs-Benke | Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases |
| WO2011013786A1 (ja) * | 2009-07-31 | 2011-02-03 | Maeda Shin | 癌の転移抑制剤 |
| US7947653B1 (en) | 2009-10-09 | 2011-05-24 | Cold Spring Harbor Laboratory | Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers |
| US8323883B1 (en) | 2009-10-09 | 2012-12-04 | Cold Spring Harbor Laboratory | Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitors |
| US8853147B2 (en) | 2009-11-13 | 2014-10-07 | Onyx Therapeutics, Inc. | Use of peptide epoxyketones for metastasis suppression |
| EP2542238B1 (en) | 2010-03-01 | 2015-08-12 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
| WO2011149051A1 (ja) | 2010-05-28 | 2011-12-01 | 中外製薬株式会社 | 抗腫瘍t細胞応答増強剤 |
| US20140294854A1 (en) * | 2011-03-10 | 2014-10-02 | Albert Einstein College Of Medicine Of Yeshiva University | Target directed to adipocytes, methods and assays for treatment of obesity |
| WO2013175276A1 (en) * | 2012-05-23 | 2013-11-28 | Argen-X B.V | Il-6 binding molecules |
| US20140105921A1 (en) | 2012-07-09 | 2014-04-17 | Onyx Therapeutics, Inc. | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors |
| KR101643041B1 (ko) * | 2014-04-25 | 2016-07-28 | 아주대학교산학협력단 | 프로테아좀 저해제 및 디히드로피리딘계 화합물을 유효성분으로 함유하는 암의 예방 또는 치료용 조성물 |
| CN108030916A (zh) * | 2015-07-03 | 2018-05-15 | 刘永庆 | 防治肿瘤和/或慢性结核病的Th2免疫反应抑制剂及其应用 |
| WO2017138008A2 (en) * | 2016-02-14 | 2017-08-17 | Yeda Research And Development Co. Ltd. | Methods of modulating protein exocytosis and uses of same in therapy |
| WO2018203545A1 (ja) | 2017-05-02 | 2018-11-08 | 国立研究開発法人国立精神・神経医療研究センター | Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法 |
| US20200246488A1 (en) * | 2017-07-17 | 2020-08-06 | The Broad Institute, Inc. | Compositions and methods for treating inflammatory bowel diseases |
| JP7235249B2 (ja) | 2017-10-20 | 2023-03-08 | 学校法人兵庫医科大学 | 抗ｉｌ－６受容体抗体を含有する術後の癒着を抑制するための医薬組成物 |
| WO2019151418A1 (ja) | 2018-01-31 | 2019-08-08 | 元一 加藤 | Ｉｌ－６阻害剤を含有する喘息の治療剤 |
| US20200165608A1 (en) * | 2018-11-23 | 2020-05-28 | Florida State University Research Foundation, Inc. | Inhibition of vascular endothelial cell-mediated phagocytic processes for treatment of demyelinating conditions |
| EP3957324A4 (en) | 2019-04-17 | 2023-02-08 | Hiroshima University | THERAPEUTIC FOR UROLOGICAL ONCOLOGY CHARACTERIZED BY BEING ADMINISTRATED IN COMBINATION WITH IL-6 INHIBITOR AND CCR2 INHIBITOR |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210075A (en) * | 1990-02-16 | 1993-05-11 | Tanabe Seiyaku Co., Ltd. | Interleukin 6 antagonist peptides |
| US5340736A (en) * | 1991-05-13 | 1994-08-23 | The President & Fellows Of Harvard College | ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| AU6808194A (en) * | 1993-05-31 | 1994-12-20 | Chugai Seiyaku Kabushiki Kaisha | Reconstructed human antibody against human interleukin-6 |
| US5888510A (en) * | 1993-07-21 | 1999-03-30 | Chugai Seiyaku Kabushiki Kaisha | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| US5693617A (en) * | 1994-03-15 | 1997-12-02 | Proscript, Inc. | Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
| KR20010080267A (ko) * | 1998-10-20 | 2001-08-22 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 프로테아솜 억제제 약물 작용을 모니터링하는 방법 |
| PT2308888T (pt) * | 2001-11-14 | 2017-05-03 | Janssen Biotech Inc | Anticorpos anti-il-6, composições, métodos e utilizações |
| WO2004071404A2 (en) * | 2003-02-04 | 2004-08-26 | Centocor Inc. | Use of il-6 antagonists in combination with steroids to enhance apoptosis |
| JO3058B1 (ar) * | 2005-04-29 | 2017-03-15 | Applied Molecular Evolution Inc | الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها |
-
2006
- 2006-12-07 AR ARP060105416A patent/AR057227A1/es not_active Application Discontinuation
- 2006-12-08 CA CA002632732A patent/CA2632732A1/en not_active Abandoned
- 2006-12-08 KR KR1020087016043A patent/KR20080072761A/ko not_active Withdrawn
- 2006-12-08 US US11/608,342 patent/US20090022726A1/en not_active Abandoned
- 2006-12-08 WO PCT/US2006/061786 patent/WO2007067976A2/en not_active Ceased
- 2006-12-08 CN CNA2006800459213A patent/CN101325969A/zh active Pending
- 2006-12-08 EA EA200870029A patent/EA014675B1/ru not_active IP Right Cessation
- 2006-12-08 AU AU2006321610A patent/AU2006321610A1/en not_active Abandoned
- 2006-12-08 JP JP2008544662A patent/JP2009518447A/ja active Pending
- 2006-12-08 EP EP06840161A patent/EP1954310A4/en not_active Withdrawn
- 2006-12-08 TW TW095145881A patent/TW200803895A/zh unknown
- 2006-12-08 BR BRPI0619498-2A patent/BRPI0619498A2/pt not_active IP Right Cessation
-
2008
- 2008-05-25 IL IL191694A patent/IL191694A0/en unknown
- 2008-06-27 NO NO20082907A patent/NO20082907L/no not_active Application Discontinuation
- 2008-07-08 ZA ZA200805956A patent/ZA200805956B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009518447A5 (https=) | ||
| Fulda | Promises and challenges of Smac mimetics as cancer therapeutics | |
| JP2009518441A5 (https=) | ||
| JP2020510662A5 (https=) | ||
| Deng et al. | Brentuximab vedotin | |
| Wright | Combination therapy of bortezomib with novel targeted agents: an emerging treatment strategy | |
| JP6177133B2 (ja) | Ｃｄ３８を特異的に認識する抗体とボルテゾミブを含有する抗腫瘍性の組合せ | |
| JP2007513073A5 (https=) | ||
| JP2014502957A5 (https=) | ||
| JP2015534577A5 (https=) | ||
| JP2008530142A5 (https=) | ||
| JP2009501800A5 (https=) | ||
| HRP20180945T1 (hr) | Konjugati protutijelo-pirolobenzodiazepin | |
| HRP20200551T1 (hr) | Axl-specifični konjugati protutijelo-lijek za liječenje raka | |
| JP2020505433A5 (https=) | ||
| RU2723937C2 (ru) | Композиции, включающие антитела к cd38 и карфилзомиб | |
| JP2020504723A5 (https=) | ||
| JP2010515709A5 (https=) | ||
| JP2007051159A5 (https=) | ||
| JP2018516969A5 (https=) | ||
| JP2010500371A5 (https=) | ||
| JP2014533279A5 (https=) | ||
| CN104039320A (zh) | 血液恶性肿瘤用抗-cxcr4抗体的治疗 | |
| JP2008507529A5 (https=) | ||
| JP2006528626A5 (https=) |